Rewriting the Hepatitis Playbook from B to C
Hepatitis B and C remain major global health threats due to persistent gaps in diagnosis, treatment access, and implementation of care.
Read More
Search Results for: liver disease
Esophageal Precancer Testing Program Launched at Hoag
Lucid Diagnostics and Hoag have launched a comprehensive esophageal precancer screening program using the non-endoscopic EsoGuard DNA test.
Read More
Should Labs Add Lp(a) Testing to Their Menus?
Lipoprotein(a), or Lp(a), is a genetically determined and under-recognized cardiovascular disease risk factor.
Read More
AI ‘Fragle’ Method Makes Cancer Tracking More Efficient
Researchers have developed an AI blood test called Fragle to accurately and affordably track cancer treatment response and detect relapse.
Read More
Access Medical Labs Transitions to Roche Diagnostics
Access Medical Labs has fully transitioned to Roche Diagnostics equipment in under 30 days, increasing testing speed, capacity & efficiency.
Read More